Search Results
May 05, 2026, 18:16 ET Multi-Stakeholder Expert Panel Finds UTI Management in the United States Represents a Solvable Systemic Failure Costing More Than $6 Billion Annually
P.M. The Increase in Hospitalizations for Urinary Tract Infections and the Associated Costs in the United States, 1998–2011. Open Forum Infect. Dis. 2017, 4, ofw281, doi:10.1093/ofid/ofw281.2 Carreno, J.J.; Tam, I.M.; Meyers, J.L.; Esterberg, E.; Candrilli, S.D.; Lodise, T.P.
More news about: Pathnostics
May 05, 2026, 16:30 ET Corteva Delivers Strong 1Q 2026, Reaffirms 2026 Outlook, On-Track for 4Q 2026 Separation
discontinued operationsOne-time separation costs4 expected to be ~$350 million, consistent with external benchmark rangesNet dis-synergies estimate of ~$100 million trending favorably; $50 million included in full-year 2026 guidanceIn April 2026, the Board of Directors
More news about: Corteva Agriscience
May 05, 2026, 10:30 ET Sebela Pharmaceuticals Presents Phase 3 Tegoprazan Data in Erosive Esophagitis at Digestive Disease Week® (DDW) 2026
2014.2Chey WD, et al. Patient and physician satisfaction with proton pump inhibitors (PPIs): are there opportunities for improvement? Dig Dis Sci. 2010.3Armstrong D, et al. Symptom Profile, Proton Pump Inhibitor Therapy, and Diagnostic Testing in Patients with
More news about: Sebela Pharmaceuticals
Apr 30, 2026, 09:07 ET JASMINE Trial Demonstrates Prolacta's Human Milk-Based Fortifiers Deliver Superior Growth in Premature Infants While Maintaining Japan's Renowned Low NEC Rate
for gestational age infants fed an exclusive human milk-based diet achieve catch-up growth without metabolic consequences at 2 years of age. Arch Dis Child Fetal Neonatal Ed. 2018;0:F1-F6. doi:10.1136/archdischild-2017-314547
More news about: Prolacta Bioscience
Apr 28, 2026, 16:05 ET PTC Therapeutics Reports Positive Topline Results from Month 24 Interim Analysis of PIVOT-HD Extension Study of Votoplam
Parkinsonism Rel Disord 2020;3:100056.Tabrizi SJ, Flower MD, Ross CA, et al. Nat Rev Neurol 2020;16(10):529–546.Roos RAC. Orphanet J Rare Dis 2010; 5:40.Kirkwood SC, Su JL, Conneally P, et al. Arch Neurol 2001;58(2):273–278.
More news about: PTC Therapeutics, Inc.
Apr 28, 2026, 09:28 ET PTC Therapeutics to Report Results from PIVOT-HD Long Term Extension Study
Parkinsonism Rel Disord 2020;3:100056.Tabrizi SJ, Flower MD, Ross CA, et al. Nat Rev Neurol 2020;16(10):529–546.Roos RAC. Orphanet J Rare Dis 2010; 5:40.Kirkwood SC, Su JL, Conneally P, et al. Arch Neurol 2001;58(2):273–278.
More news about: PTC Therapeutics, Inc.
Apr 28, 2026, 08:00 ET AbbVie Submits Application to FDA for Upadacitinib (RINVOQ®) for Adults and Adolescents with Severe Alopecia Areata
Acad Dermatol. 2010;62(2):177-188, quiz 189-190. Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Primers. 2017;3(1):17011 Davey L, Clarke V, Jenkinson E. Living with alopecia areata: an online qualitative survey study. Br J Dermatol.
More news about: AbbVie
Apr 27, 2026, 08:05 ET AbbVie Submits Regulatory Application to FDA for SKYRIZI® (risankizumab-rzaa) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease
Hepatol. 2015 Dec;12(12):720-7. doi: 10.1038/nrgastro.2015.150.Gajendran M, et al. A comprehensive review and update on Crohn's disease. Dis Mon. 2018 Feb;64(2):20-57. doi: 10.1016/j.disamonth.2017.07.001.A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab
More news about: AbbVie
Apr 22, 2026, 08:05 ET IMAAVY® (nipocalimab-aahu) shows over two years of sustained disease control in a broad population with generalized myasthenia gravis (gMG)
doi: 10.1097/WCO.0b013e32833c32af.xviii Finnis MF, Jayawant S. Juvenile myasthenia gravis: a paediatric perspective. Autoimmune Dis. 2011;2011:404101. doi: 10.4061/2011/404101.xix Haliloglu G, Anlar B, Aysun S, Topcu M, Topaloglu H, Turanli G, Yalnizoglu D. Gender
More news about: Johnson & Johnson
Apr 21, 2026, 09:00 ET MUG® Root Beer and George Kittle Mix Up MUG Brotein: The DIY Gainz Hack Built for "Gym Dawgs"
George Kittle to drop MUG Brotein lets us unleash that big dawg energy in fit season—creating a gainz hack that's as fun as it is delicious.""Dis one is for all da dawgz that werk hard fur da gainz. Lift heavy. Sip MUG Brotein. Get sumthin to flex abut," said MUG mascot, Dog.Missed the
More news about: PepsiCo Beverages North America
Apr 15, 2026, 08:00 ET Waters Announces CE Mark for Next-Generation Fully Automated BD BACTEC FXI Culture System for Bloodstream Infection Diagnosis
Juretschko S. Active Monitoring and Feedback to Improve Blood Culture Fill Volumes and Positivity Across a Large Integrated Health System. Clin Infect Dis. 2020 Jan 2;70(2):262-268. doi: 10.1093/cid/ciz198.Specification Data on File, Becton, Dickinson and Company 2026Gray A, Chung E, Hsu
More news about: Waters Corporation
Apr 13, 2026, 03:43 ET Lundbeck to showcase new neurology data at the American Academy of Neurology Annual Meeting
LinkedIn.References:[i] Jellinger KA. J Alzheimers Dis. 2018;62:1141–79[ii] Headache Classification Committee of the International Headache Society (IHS). The International Classification
More news about: H. Lundbeck A/S
Apr 13, 2026, 03:40 ET Lundbeck to showcase new neurology data at the American Academy of Neurology Annual Meeting
LinkedIn.References:[i] Jellinger KA. J Alzheimers Dis. 2018;62:1141–79[ii] Headache Classification Committee of the International Headache Society (IHS). The International Classification
More news about: H. Lundbeck A/S
Apr 10, 2026, 07:16 ET BD introduce un'innovazione TIPS di nuova generazione per migliorare il trattamento dell'ipertensione portale in tutta l'Unione Europea
doi: 10.1371/journal.pone.0328492 Carroll A, Boike JR. Tips for TIPS recipients: A patient-focused guidance on TIPS. Clin Liver Dis (Hoboken). 2024;23(1):e0091. doi:10.1097/CLD.0000000000000091
More news about: BD (Becton, Dickinson and Company)
Apr 09, 2026, 06:20 ET Kelun-Biotech Approved by HKEX to Remove "B" Marker from Stock Code, Representing a New Stage of Development
the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules"), the Stock Exchange has approved the dis-application of Rules 18A.09 to 18A.11 of the Listing Rules to the Company. As the Company has satisfied the relevant requirements under the Listing Rules,
More news about: Kelun-Biotech
Apr 08, 2026, 06:50 ET BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union
doi: 10.1371/journal.pone.0328492 Carroll A, Boike JR. Tips for TIPS recipients: A patient-focused guidance on TIPS. Clin Liver Dis (Hoboken). 2024;23(1):e0091. doi:10.1097/CLD.0000000000000091
More news about: BD (Becton, Dickinson and Company)
Apr 08, 2026, 06:50 ET BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union
doi: 10.1371/journal.pone.0328492 Carroll A, Boike JR. Tips for TIPS recipients: A patient-focused guidance on TIPS. Clin Liver Dis (Hoboken). 2024;23(1):e0091. doi:10.1097/CLD.0000000000000091
More news about: BD (Becton, Dickinson and Company)
Apr 08, 2026, 06:50 ET BD stellt die nächste Generation der TIPS-Technologie vor, um die Behandlung der portalen Hypertonie in der gesamten Europäischen Union voranzubringen
doi: 10.1371/journal.pone.0328492 Carroll A, Boike JR. Tips for TIPS recipients: A patient-focused guidance on TIPS. Clin Liver Dis (Hoboken). 2024;23(1):e0091. doi:10.1097/CLD.0000000000000091
More news about: BD (Becton, Dickinson and Company)
Apr 08, 2026, 06:50 ET BD ofrece la tecnología TIPS para impulsar la atención de la hipertensión portal en toda la Unión Europea
doi: 10.1371/journal.pone.0328492 Carroll A, Boike JR. Tips for TIPS recipients: A patient-focused guidance on TIPS. Clin Liver Dis (Hoboken). 2024;23(1):e0091. doi:10.1097/CLD.0000000000000091
More news about: BD (Becton, Dickinson and Company)
Apr 08, 2026, 06:50 ET BD propose une innovation TIPS de nouvelle génération pour faire progresser les soins de l'hypertension portale dans l'Union européenne
10.1371/journal.pone.0328492 Carroll A, Boike JR. Conseils pour les bénéficiaires de TIPS : Un guide sur les TIPS axé sur le patient. Clin Liver Dis (Hoboken). 2024;23(1):e0091. doi:10.1097/CLD.0000000000000091
More news about: BD (Becton, Dickinson and Company)
Mar 28, 2026, 16:45 ET REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
I, et al. Outcomes of patients with normal LDL-cholesterol at admission for acute coronary syndromes: lower is not always better. J Cardiovasc Dev Dis. 2024;11(4):120.
More news about: Amgen
Mar 28, 2026, 15:15 ET Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity
2015;373(14):1329-1339.7 Mease PJ, et al. Ann Rheum Dis. 2017;76(1):79-87.8 Deodhar A, et al. Lancet. 2020;395(10230):1115-1125.9 Kristensen LE, et al. Ann Rheum Dis. 2022;81(2):225-231.10 McInnes IB, et al. Lancet.
More news about: Eli Lilly and Company
Mar 27, 2026, 09:00 ET UCB Announces New BIMZELX® (bimekizumab-bkzx) Data at AAD Showing Durable Symptom Control Throughout Three Years in Hidradenitis Suppurativa
to assess HS severity. Br J Dermatol. 2017;177(5):1401–09.Sabat R, Jemec GBE, Matusiak L, et al. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020;6(1):18.Kimball AB, Jemec GBE, Yang M, et al. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis
More news about: UCB
Mar 23, 2026, 06:59 ET Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD)
Matsuyama S, Otsubo T, Nomoto K, Higa S, Takashio O. Prevalence of Generalized Anxiety Disorder in Japan: A General Population Survey. Neuropsychiatr Dis Treat. 2024;20:1355-1366.Forward-Looking StatementsThis press release includes statements that constitute "forward-looking
More news about: Viatris Inc.
Mar 19, 2026, 10:00 ET DESLOC Smart Lock Introduced K120 with GPT Fingerprint Access and Year-Long Power for Everyday Reliability
Amazon.com for a suggested retail price of $169.99. It is currently available for $127.49 with code PRK120DIS, valid through April 20, 2026, at 11:59 PM.About DESLOCDESLOC is a smart lock solutions brand under DESMAN, a leading professional
More news about: DESLOC